Barlow David S

CIK 00012990652 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001299065

Recent Transactions

50 trades

Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2011-01-28$0.16/sh−6,000→ 2,391,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2011-01-28$0.17/sh−9,000→ 2,382,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2011-01-28$0.15/sh−17,000→ 2,403,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2011-01-28$0.17/sh−21,000→ 2,361,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2011-01-28$0.14/sh−6,000→ 2,397,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2011-01-27$0.18/sh−5,000→ 2,420,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2011-01-27$0.17/sh−33,000→ 2,425,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-12-17$0.20/sh−122,000→ 2,458,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-12-17$0.19/sh−31,000→ 2,582,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-12-17$0.21/sh−2,000→ 2,580,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-12-16$0.22/sh−19,000→ 2,615,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-12-16$0.21/sh−24,000→ 2,634,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-12-16$0.23/sh−2,000→ 2,613,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-14$2.05/sh−300→ 2,660,877 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-14$1.97/sh−314→ 2,659,063 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-14$2.04/sh−1,000→ 2,659,877 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-14$1.96/sh−500→ 2,661,177 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-14$2.05/sh−500→ 2,663,177 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-14$1.95/sh−500→ 2,662,177 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-14$1.99/sh−500→ 2,661,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-14$1.97/sh−500→ 2,658,563 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-14$1.95/sh−500→ 2,662,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-14$1.95/sh−500→ 2,659,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-14$2.04/sh−500→ 2,663,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-14$1.95/sh−186→ 2,658,377 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-12$2.08/sh−500→ 2,665,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-12$2.08/sh−500→ 2,666,177 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-12$2.06/sh−200→ 2,667,977 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-12$2.07/sh−800→ 2,667,177 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-12$2.09/sh−500→ 2,666,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-12$2.08/sh−500→ 2,664,177 total
Sale
Molecular Insight Pharmaceuticals, Inc.
COMMON STOCK
2010-01-12$2.08/sh−1,000→ 2,664,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-24$2.34/sh−500→ 2,669,177 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-24$2.34/sh−500→ 2,668,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-24$2.34/sh−1,000→ 2,669,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-24$2.34/sh−1,000→ 2,669,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-24$2.34/sh−500→ 2,669,177 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-23$2.34/sh−500→ 2,668,177 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-23$2.31/sh−2,000→ 2,681,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-23$2.37/sh−900→ 2,676,777 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-23$2.36/sh−100→ 2,670,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-23$2.33/sh−1,000→ 2,678,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-23$2.31/sh−2,000→ 2,681,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-23$2.32/sh−2,000→ 2,679,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-23$2.33/sh−1,000→ 2,677,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-23$2.37/sh−900→ 2,676,777 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-23$2.33/sh−1,000→ 2,678,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-23$2.41/sh−1,000→ 2,671,777 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-23$2.36/sh−100→ 2,670,677 total
Sale
Molecular Insight Pharmaceuticals, Inc.
common stock
2009-12-23$2.40/sh−2,000→ 2,674,777 total

Companies

Recent Filings

Address

640 LEWIS WHARF

BOSTON, MA, 02110

View on SEC.gov